SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-113321
Filing Date
2024-10-07
Accepted
2024-10-07 17:19:00
Documents
83
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-K ktra-20240630.htm   iXBRL 10-K 2669184
2 EX-3.24 ktra-ex3_24.htm EX-3.24 19277
3 EX-3.25 ktra-ex3_25.htm EX-3.25 19277
4 EX-3.26 ktra-ex3_26.htm EX-3.26 19277
5 EX-10.32 ktra-ex10_32.htm EX-10.32 43208
6 EX-21.1 ktra-ex21_1.htm EX-21.1 2693
7 EX-23.1 ktra-ex23_1.htm EX-23.1 4691
8 EX-31.1 ktra-ex31_1.htm EX-31.1 16893
9 EX-31.2 ktra-ex31_2.htm EX-31.2 16123
10 EX-32.1 ktra-ex32_1.htm EX-32.1 9368
11 GRAPHIC img140589240_0.jpg GRAPHIC 86852
12 GRAPHIC img140589240_1.jpg GRAPHIC 82960
  Complete submission text file 0000950170-24-113321.txt   10427571

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ktra-20240630.xsd EX-101.SCH 1630781
86 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20240630_htm.xml XML 1481351
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-37823 | Film No.: 241358615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)